References
- 1. Babose TDJr. American Society of Nephrology presidential address 2006: chronic kidney disease as a public health threat: new strategy for a growing problem. J Am Soc Nephrol. 2008; 18:1038-45.
- 2. Parving HH, Lehnert H, Brochner -Mortensen J, Gomis R, Anderson S, Arner P, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001; 345:870-8.
- 3. Futrakul N, Vongthavarawat V, Sirisalipotch S, Chairatanarat T, Futrakul P, Suwanwalaikorn S. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc. 2005; 32:59-65.
- 4. Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999; 33:886-91.10.1016/S0272-6386(99)70421-X
- 5. Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007; 1:33-44.
- 6. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy (late). Ren Fail. 2009; 31:207-10.
- 7. Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc. 2008; 38:201-7.
- 8. Futrakul N, Butthep P, Futrakul P, Sitprija V. Improvement of renal function in type 2 diabetic nephropathy. Ren Fail. 2007; 29:155-8.
- 9. Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, et al. Renal vascular endothelial function in hypertensive patients with type 2 diabetis mellitus. Am J Kidney Dis. 2009; 53:281-9.
- 10. Futrakul N, Futrakul P. Improved vascular repair is relevant to enhanced renal function with vasodilators in early stage of chronic kidney disease. Asian Biomed. 2010; 4:153-7.
- 11. Futrakul N, Futrakul P. Vascular repair is vulnerable to renal regeneration in early stage of diabetic nephropathy (letter to editor). Asian Biomed. 2010; 4: 827-8.
- 12. Bohle AC, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res. 1996; 19:191-5.
- 13. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002; 13:806-816.10.1097/01.ASN.0000034910.58454.FD
- 14. Nakagawa T, Kang DH, Ohashi R, Suga S, Herrera- Acosta J, Rodriguez-Iturbe B, et al. Tubulointerstitial disease: role of ischemia and microvascular disease. Cur Opin Nephrol Hyperten. 2003; 12:233-41.
- 15. Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A, Watanapenphaibul K, et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren Fail. 2000; 22: 329-35.
- 16. Futrakul N, Butthep P, Vongthavarawat V, Futrakul P, Sirisalipoch S, Chairatanalat T, et al. Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc. 2006; 34: 373-382.
- 17. Futrakul N, Futrakul P, Siriviriyakul P. Corection of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis. Clin Hemorheol Microcirc. 2000; 31:197-205.
- 18. Kawasaki K, Smith RS, Hsinh C-M, Sun J, Chao J, Liao JK. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway modiates nitric oideinduced endothelial cell migration and angiogenesis. Mol Cell Biol. 2003; 23:5726-37.